Department of Ophthalmology, Chang Gung Memorial Hospital, Linkou Branch, Taoyuan, Taiwan.
College of Medicine, Chang Gung University, Taoyuan, Taiwan.
Med Mycol. 2020 Apr 1;58(3):293-299. doi: 10.1093/mmy/myz059.
Paecilomyces/Purpureocillium species is an emerging pathogen of fungal keratitis; the risk factor, clinical course, and outcome of Paecilomyces/Purpureocillium keratitis need more exploration. We retrospectively reviewed 12 patients with culture-proven Paecilomyces/Purpureocillium keratitis in our hospital from 2003 to 2017 and combined them with 50 previous cases reported after the review conducted by Yuan et al. in 2009. Clinical features between the previously and newly reported cases were compared using the publication by Yuan et al. as a cutoff point. The mean age of the 62 newly reported patients with Paecilomyces/Purpureocillium keratitis was 52.7 years. Of these, contact lens wear was the most common predisposing factor (n = 32, 52%), followed by a preexisting corneal disease or previous ocular surgery (n = 12, 19%), and trauma (n = 8, 13%). Fifty eyes (81%) were treated with voriconazole, of which 31 (63%) were medically cured. Twenty-one of 62 eyes (34%) required therapeutic surgery. Compared with the 42 patients reported by Yuan et al., the patients were younger (P = .025); a higher proportion of the patients were contact lens wearers (P = .005); more patients were treated with voriconazole (P = .000); fewer patients required therapeutic surgery (P = .000) in recent reports. Contact lens use has become the major risk factor for Paecilomyces/Purpureocillium keratitis. The surgical rate has been significantly lower in recent publications, probably because of the prevalent use of voriconazole.
棘孢木霉/佩氏拟青霉是一种新兴的真菌性角膜炎病原体;棘孢木霉/佩氏拟青霉角膜炎的危险因素、临床病程和结局需要进一步探索。我们回顾性分析了 2003 年至 2017 年我院经培养证实的 12 例棘孢木霉/佩氏拟青霉角膜炎患者,并结合袁等人 2009 年回顾性研究后报道的 50 例病例。以袁等人的研究报告为截止点,比较了以前和新报告病例的临床特征。62 例新报告的棘孢木霉/佩氏拟青霉角膜炎患者的平均年龄为 52.7 岁。其中,戴隐形眼镜是最常见的诱发因素(n = 32,52%),其次是角膜疾病或先前眼部手术(n = 12,19%)和外伤(n = 8,13%)。50 只眼(81%)用伏立康唑治疗,其中 31 只眼(63%)治愈。62 只眼中有 21 只(34%)需要手术治疗。与袁等人报道的 42 例患者相比,近期报告的患者年龄更小(P =.025);戴隐形眼镜的患者比例更高(P =.005);更多的患者接受伏立康唑治疗(P =.000);需要手术治疗的患者更少(P =.000)。隐形眼镜的使用已成为棘孢木霉/佩氏拟青霉角膜炎的主要危险因素。在最近的出版物中,手术率显著降低,可能是因为伏立康唑的广泛应用。